UPMC Passavant HOA — Pittsburgh, Pennsylvania

UPMC Passavant HOA is a clinical research site located in Pittsburgh, Pennsylvania, United States 15237.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Passavant HOA has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Passavant HOA?

UPMC Passavant HOA has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Passavant HOA conducted?

UPMC Passavant HOA has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Is UPMC Passavant HOA accredited by Crixeo Health?

UPMC Passavant HOA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Passavant HOA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.